dihexa nasal spray (10 MG) Dihexa Research Nasal Spray —

No cell-related safety issues were encountered in this trial, although the patients receiving 18*10 6 MSCs showed a higher incidence of adverse effects ( Lastly, several human growth factor-based phase I/II clinical trials were started to evaluate the safety, tolerability, and preliminary effectiveness of intradiscal delivery of growth and differentiation factor-5 (GDF-5) as compared with placebo (sterile water/vehicle control) in human patients with early lumbar disc degeneration in the United States, Australia, and the Republic of Korea

PI3K: phosphoinositide 3-kinase

It is sold exclusively for laboratory research and is not FDA-approved for any clinical application

These peptides support the repair of tendons, ligaments, muscle, intestinal lining, and neuronal tissue by the peptide

10.1056/NEJMoa2209604 N

[DOI] [PubMed] [Google Scholar] 174.Drmic D., Samara M., Vidovic T., Malekinusic D., Antunovic M., Vrdoljak B., Ruzman J., Milkovic Perisa M., Horvat Pavlov K., Jeyakumar J., et al